Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd., explained in plain language.
-
New drug SHR-4298 enters early human trials for hard-to-treat cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called SHR-4298 in 200 adults with advanced solid tumors that have spread or come back. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors or slow their growth. Participants must have good organ fu…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New combo therapy aims to fight tough bladder cancer without removing the bladder
Disease control Not yet recruitingThis phase 3 study tests a new drug (SHR-1501) given directly into the bladder along with BCG, compared to standard chemotherapy, in people with high-risk bladder cancer that no longer responds to BCG alone. The goal is to see if the combination helps keep the cancer from coming …
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for advanced lung cancer: experimental drug SHR-1826 enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called SHR-1826 in 90 adults with advanced or metastatic non-small cell lung cancer that has worsened after other treatments. Participants receive the drug by IV every three weeks. The goal is to see if the drug shrinks tumors and to check its safety.
Phase: PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC